Atlas Trials

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

Clinical trial NCT02332889 · TERMINATED

Trial details

NCT number
NCT02332889
Sponsor
University of Louisville
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
GliomasMedulloblastomaNeuroectodermal Tumors, Primitive
Start date
2015-04-01
Primary completion
2016-07-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.